RoundTable Healthcare Partners (RoundTable), an operating-oriented private equity firm focused exclusively on the healthcare industry, has closed its fifth equity fund at USD700 million in capital commitments.
RoundTable closed its first equity fund of USD400 million in March 2002, its second equity fund of USD500 million in March 2005, its third equity fund of USD600 million in July 2010, and its fourth equity fund of USD650 million (Fund IV) in August 2015.
RoundTable’s long-standing strategy has been to utilise the firm’s extensive healthcare operating and transaction expertise to improve the growth and profitability of its portfolio companies to enhance their value and generate attractive investment returns. The firm focuses its investments on family companies, owner/founders, management teams and corporate partners who have confidence in RoundTable’s ability to add value beyond capital.
To advance this strategy, Fund V will be overseen by a Management Committee consisting of Thomas P Kapfer, Pierre Fréchette, and R Craig Collister, all three of whom served on the Management Committee for Fund IV. Messrs. Kapfer and Fréchette will continue to lead the firm’s operating resources and chair the firm’s portfolio companies. Collister will head the firm’s transaction activities. Together, the three will function as Managing Partners. Kapfer will serve as Chairman of the Management Committee.
With the formation of Fund V, Barb Sullivan will assume the role of Operating Partner, Chief Financial Officer, and Chief Compliance Officer. Most recently, Sullivan served as Senior Vice President, Finance at RoundTable having previously been the Chief Financial Officer for two of RoundTable’s prior portfolio companies.
Additionally, three individuals on the transaction team were promoted. Andrew B Hochman was named Senior Partner and will continue to focus on the firm’s pharmaceutical and consumer health investments. Hochman joined RoundTable in 2007. Jawwad A Akhtar and Phillip S Smith II were promoted to Principal. Akhtar joined RoundTable in 2011 and focuses on pharmaceutical and consumer health investments. Smith joined RoundTable in 2009 and focuses on medical product and medical device investments.
“We are committed to our strategy of investing in healthcare companies that can benefit from our strong operating and transaction expertise,” says Kapfer. “This strategy produces strong deal flow, investment returns, and investor loyalty. The vast majority of Fund V investors have been with us since the firm’s inception in 2001. We thank them for their ongoing support and commitment.”
